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ress: 14 Midmar Drive,Summary Although the principles of asthma management are well established in
Europe, the available data indicate that asthma in patients is not well controlled.
Many patients derive incomplete benefit from their inhaled medication because they
do not use inhaler devices correctly and this may compromise asthma control. The
Aerosol Drug Management Improvement Team (ADMIT), incorporating clinicians from
the UK, Germany, France, Italy, Spain and The Netherlands, reviewed published
evidence to examine ways to improve the treatment of reversible airways disease in
Europe. Data indicate that there is a clear need for specific training of patients in
correct inhalation technique for the various devices currently available, and this
should be repeated frequently to maintain correct inhalation technique. Devices
which provide reassurance to patients and their physicians that inhalation isElsevier Ltd. All rights reserved.
131 447 1022; fax: +44 (0)131 466 2717.
co.uk (G.K. Crompton).
Edinburgh, EH10 6BU, Scotland, UK.
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G.K. Crompton et al.1480performed correctly should help to improve patient compliance and asthma control.
Educational efforts should also focus on primary prescribers of inhaler devices.
ADMIT recommends dissemination of information on the correct inhalation technique
for each model of device by the use of an accessible dedicated literature base or
website which would enable to match the appropriate inhaler to the individual
patient. There is also a need for standardisation of prescribing practices throughout
Europe. Regular checking of inhalation technique by prescribers is crucial as correct
inhalation is one of the keystones of successful asthma management.
& 2006 Elsevier Ltd. All rights reserved.Contents
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ment guidelines following the introduction of the
bronchodilator containing pressurised metered
dose inhaler (pMDI) in the 1950s and inhaled
corticosteroid (ICS) therapy some 20 years later
many asthma patients in Europe do not obtain full
clinical benefit from this treatment, but the
reasons for this are far from clear.1
The inability of many patients to use their pMDIs
correctly is one possible explanation.2–6 Efficient use
of pMDIs requires coordination between simulta-
neous inhalation and device actuation, a slow and
continuous inspiratory flow rate during inhalation
followed by a breath hold of at least 10 s.7 Also,
patients frequently fail to exhale fully before
inhalation of the medication,8,9 and they actuate
the pMDI before or at the end of inhalation, or while
breath-holding.2,9 When used with a spacer device,
pMDIs are bulky, which may reduce patient com-
pliance, and without a spacer device a high
proportion of the drug is deposited in the mouth
and oropharynx.10 There is no evidence that the
introduction of breath-actuated pMDIs and various
spacer attachments have made the pMDIs easier to
use.11 Moreover, the available pMDIs provide no
inhalation feedback mechanisms or a dose counter
and contain environmentally unfriendly propellants.
In the 1980s, dry powder inhalers (DPIs) were
introduced with the aim to avoid the need for
coordination between inhalation and actuation ofthe device. Inhaler ease of use and patient pre-
ference can influence compliance with therapy, as
indicated by recent studies with DPIs.12,13 In one
study in patients with symptomatic chronic obstruc-
tive pulmonary disease (COPD),12 58% of the patients
reported no problems using the Diskuss compared
with only 11% using the Handihalers; 72% of the
patients also reported that they would not be happy
to use the Handihalers. In another study,13 although
compliance with the Easyhalers and Turbuhalers
was high (497%), twice as many patients with
asthma favoured the Easyhalers over the Turbuha-
lers (59% vs. 33%), and scores of device acceptability
significantly favoured the Easyhalers (P ¼ 0:001).
Many physicians in Europe are fully aware of the
difficulties that patients have using the prescribed
inhaler devices correctly and the negative impact
that this may have on asthma control.14 The Aerosol
Drug Management Improvement Team (ADMIT),
incorporating experts from the UK, Germany, France,
Italy, Spain and The Netherlands, was formed in
November 2004 with the remit of examining ways to
improve the treatment of reversible airways disease
in Europe. ADMIT reviewed evidence from published
studies relating to inhalation technique. Details of
these studies are summarised by country in Table 1,
and findings are discussed below.Methods
We conducted a literature search in PubMed up to
and including the year 2005 for articles investigating
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countries. Search terms used were [inhalation] or
[inhalation technique] or [inhaler] or [device] and
[country] where country was Spain, Italy, France,
Germany, The Netherlands or the UK (including
searches for England, Scotland, Wales and Northern
Ireland). A separate search using only the search
term [inhalation technique] was also conducted.
Each abstract was scanned and those articles deal-
ing specifically with inhalation technique of patients
or healthcare professionals in any of the selected
countries were chosen for review.Inhalation technique: review of evidence
from Europe
Spain
The available data indicate that a substantial
proportion of patients, as well as medical and
nursing personnel in Spain does not know how to
use inhalers correctly, despite physicians’ aware-
ness of the importance of correct inhalation
technique for treatment outcome. In a nationwide
sample of patients (n ¼ 746) and medical personnel
(466 nurses and 428 physicians),4 substantial
deficiencies were observed, with only 9% of the
patients, 15% of the nurses and 28% of the
physicians being able to perform the inhalation
manoeuvre correctly (Table 1). Other studies have
produced similar results, with inhalation technique
deficiencies particularly apparent with pMDIs (Ta-
ble 1).15–17 The most common errors associated
with pMDI use were not holding the breath after
inhalation, not waiting 30 s between inhalation
manoeuvres and lack of coordination between
actuation and inhalation.15 In addition, lack of
correct inhalation technique was associated with
the absence of instruction before use and younger
age.15 Moreover, in a different study18 assessing the
correct use of the Turbuhalers by 118 healthcare
professionals, only 32% of the nurses and 56% of the
physicians were able to perform the required deep,
forcible sudden inhalation essential for the correct
use of this device (Table 1). Training in the use of
inhaler devices may improve inhalation techni-
que15,34 and should start with healthcare profes-
sionals directly involved in asthma management.Italy
There is a scarcity of data relating to inhaler
technique in Italy. However, a recently published
study in 1404 experienced outpatients showed that
24% of had incorrect inhalation technique with
pMDIs, 17% were unable to use correctly the
Aerolizers, and 23% and 24% the Diskuss and theTurbuhalers, respectively (Table 1).19 There are
some data available relating to the use of nebuli-
sers, which provides useful insight into inhaled drug
delivery in Italy. The GENEBU project20,21 showed
that the vast majority of the patients selected their
nebuliser themselves without any medical advice
and did not receive information on the interface
system or the optimal fill volume of the nebuliser
(Table 1). Nebuliser equipment for home use in
Italy is heterogeneous and probably not always
utilised effectively. It seems likely that the same
pattern of insufficient instruction would be the
case for other inhaler devices.
Guidelines on the correct use and maintenance
of nebulisers have been published recently35,36 and
their implementation should help to improve the
prescription of aerosol therapy with nebulisers and
teach the patients best practice for home treat-
ment. But, prescription of pMDIs or DPIs should be
encouraged where appropriate, as these devices
are easier to use correctly.
France
Physicians in France recognise that poor compli-
ance is a major barrier to the achievement of good
asthma control, with incorrect inhalation techni-
que contributing most, particularly in children and
elderly patients.37
Data from France suggest that there are differ-
ences in use of inhaler devices in real life in the
primary care setting compared to controlled
clinical studies. In one study,23 which examined
the correct use of inhaler devices in 3811 patients
treated for at least 1 month with either the
Aerolizers, the Autohalers, the Diskuss, the
Accuhalers, a pMDI or the Turbuhalers devices,
more patients made at least one error in inhalation
technique with the pMDI than with the breath-
actuated devices (76% vs. 49–55%); additionally,
more errors in inhalation technique compromising
treatment efficacy were made with the pMDI or the
Turbuhalers compared to the other devices.
Furthermore, general practitioners (GPs) overesti-
mated good inhaler technique more often for the
Turbuhalers than for the Autohalers and pMDI
devices (24% vs. 6%) (Table 1).
Errors that may detrimentally influence the
efficiency of inhalation treatment in infants are
also common. Most of these errors could be avoided
by spending more time informing and training
parents on the correct use of the devices. In one
study,24 only 47% of the parents received training in
administration of treatment through the relevant
spacer device. However, it is worth noting that
healthcare professionals responsible for teaching
patients how to use their inhaler(s) frequently have
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(Table 1).22 Children often experience difficulty
using pMDIs without a spacer device. The extent of
drug delivery also varies with different spacer
devices as well as different interfaces. In one study
in young children,25 successful drug delivery with
the pMDI used with the recommended holding
chamber (BabyHalers or Nebuchambers) de-
pended not only on patient age and type of holding
chamber but also on inhalation interface (i.e.
facemask or mouthpiece). Whether such factors
have any effect on treatment efficacy or compli-
ance has yet to be determined. It is clear, however,
that there is a need for continued education of
prescribers and users in the correct use of these
devices to improve treatment outcome.
Germany
A recent study carried out in 125 device-naı¨ve
symptomatic patients with COPD showed that 42%
of them experienced difficulty using the Diskuss
correctly compared with 81% who were unable to
use the Handihalers correctly12 (Table 1). The
Diskuss was rated higher than the Handihalers for
the top three features of an ideal inhaler and,
overall, more patients preferred the Diskuss.12
Another study used a new system (Inhalation
Manager) developed in Germany to assess the
inhalation technique of patients using original
devices under everyday conditions.26 Results for
patients aged between 18 and 59 years showed that
improvement in inhalation technique was required
for only 1.5% of the patients using the Autohalers
compared with 16.7% and 38.9% using the Diskuss
and the Turbuhalers, respectively. There was also
evidence that inhalation technique was worse in
patients of higher age (Table 1).26 Clearly, there is a
need for improvement of inhaler technique, parti-
cularly in older patients. Indeed, the Working
Group ‘‘Patient Training’’ of the German Society
of Pneumology reports that patient training mea-
sures (including inhalation technique) have been
markedly broadened for patients suffering from
obstructive airway disease,38 but there is still some
way to go.
The Netherlands
Data from The Netherlands indicate that compre-
hensive inhalation instruction and repeated follow-
up are needed to ensure correct inhalation techni-
que.30,39 In one study in children,30 inhalation
technique was scored using criteria defined by
The Netherlands Asthma Foundation and perfor-
mance was related to the inhalation instructions
given by the GP or pharmacist. For each inhaler, a
number of steps were considered essential forsuccessful drug delivery. Newly referred patients
were asked to demonstrate their inhalation tech-
nique and to complete a questionnaire on the
inhalation instruction received prior to referral.
Although 91% of the patients had received inhala-
tion instruction prior to referral, only 29% of these
patients using a DPI performed all essential steps
correctly, compared with 67% using a pMDI/spacer
combination (Po0:01). Moreover, children who had
received comprehensive inhalation instructions
with repeated checks of correct inhalation techni-
que at the pharmacy or in the clinical trial setting
were more likely to perform all essential steps
correctly than children who had received a single
instruction by a GP (Table 1). These results have
been confirmed in other studies.39,40
Improvement in correct use of DPIs after instruc-
tion and training has also been reported. In one
study,29 patients who administered at least one
drug using the Diskhalers or the Diskuss/Accuha-
lers were asked to demonstrate their inhalation
technique in the outpatient clinic. After instruc-
tion, the percentage of patients who performed all
essential steps correctly increased and almost all
steps were performed correctly at the second visit
(Table 1). van der Palen et al.31 reported that of
166 patients with asthma who used the same
inhaler for a year, 72% performed all essential
inhalation steps correctly and the number in-
creased to 80% after 1 year. Patients using the
Diskhalers made the fewest errors. Interestingly,
at follow-up, older patients were less likely to
perform all essential steps for inhalation
correctly.31
Incorrect inhalation technique is common among
patients with pulmonary disease in primary care. In
one study in patients with COPD,32 over 33% of the
patients had a very poor inhalation technique and
only 42% of the patients performed all essential
steps for inhalation correctly. More patients per-
formed all essential steps correctly with the
Diskhalers compared with those patients using
the Rotahalers or the Turbuhalers. Results from
another study have shown that out of 131 patients
with COPD in The Netherlands 31% experienced
problems using the Diskuss and 68% experienced
problems with the Handihalers.12
Investigators have attempted to identify factors
associated with correct inhalation technique. Re-
sults from one study27 showed that children
attending a hospital-based asthma unit who had
received repeated instructions and children who
had previously been asked to demonstrate the use
of their inhaler during an instruction session were
significantly more likely than other children to have
a correct inhalation technique (Po0:001 and
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referred children demonstrating a correct inhala-
tion technique improved from 57.4% to 97.9% after
three comprehensive instruction sessions.27 A study
in 558 patients with asthma or COPD28 showed that
the type of inhaler appeared to be the strongest
independent determinant of an incorrect inhalation
technique. Patients using the Rotahalers/Spinha-
lers, the Turbuhalers, a pMDI or the Cyclohalers/
Inhaler-Ingelheim were at a significantly higher risk
of making mistakes using the devices than those
using the Diskhalers (odds ratio [OR] 16.08, 13.17,
11.60 and 3.27, respectively). Other significant
determinants of an incorrect inhalation technique
were low emotional quality of life (OR 1.73) and
being treated in a group practice (OR 2.26).28United Kingdom
Use of pMDIs in the UK has been extensively
investigated over the period from 1982 to
2000.2,3,5,6 In 1982, 59% of outpatients who had
not used an inhaler before and who attended
hospital during a 3-month period, were unable to
use a pMDI correctly after reading the instruction
pamphlet or after receiving instruction by demon-
stration if they did not understand the pamphlet.2
Problems encountered using the pMDI included
difficulty coordinating aerosol actuation with in-
halation (54% of the patients), stopping inhalation
after actuation of the aerosol (24%) and breathing
through the nose whilst actuating the aerosol in the
mouth (12%).2 Subsequent studies3,5,6 showed that
the percentage of patients able to use a pMDI
correctly after reading the instruction pamphlet or
after receiving instruction continued to fall in time
(Table 1).
Surprisingly, previous ability to use a pMDI
correctly was not indicative of correct use during
subsequent testing.2,33 In one study,33 14% of the
patients who had previously been able to use an
inhaler correctly subsequently proved to have
totally inefficient coordination of inhalation and
inhaler actuation. A later study2 in 1038 patients
already treated by inhalation showed that 13% of
these patients subsequently had a poor inhalation
technique even though they had previously demon-
strated correct use of their inhalers.
Taken together, these observations suggest that
the majority of patients with asthma in the UK
probably derive incomplete benefit from the use of
pMDIs. Although training apparently results in a
more efficient use of the devices, training sessions
must be repeated and the results checked at
regular intervals.Discussion and conclusions
Review of the available data indicates that up
to 50% of patients in Europe are unable to use
their inhaler devices correctly, and up to 40% of
children make inhalation technique errors
even with spacers.30,41 Poor inhalation technique
may have significant implications for treatment
compliance and efficacy and, most importantly, will
impact on the patient’s confidence in her/his
asthma management plan. International asthma
management guidelines (GINA)42 provide little
information on inhaler choice and correct inhala-
tion technique. Furthermore, there is no obje-
ctive compilation of the required inhalation tech-
nique for each of the inhaler devices currently
available.
Asthma continues to be a poorly controlled
disease. However, it is not known to what extent
incorrect inhalation technique influences asthma
control or how it can be objectively measured.
Indeed, the question becomes more complicated
when one considers that incorrect inhalation
technique may have a direct impact on treatment
compliance.
In children, poor inhalation technique depends
on age. A recent study by Dubus and Anhoj25
showed that the amount of corticosteroid inhaled
through a pMDI and holding chamber increased with
age and more drug was delivered through the
Nebuchambers than through the BabyHalers even
in very young infants (1–2 months). Use of a
facemask rather than a mouthpiece interface also
increased the dose of corticosteroid delivered.25 In
adults (20–81 years), there does not appear to be
an age-dependent effect on inhalation technique
through a pMDI; most patients use their pMDI
incorrectly, but females of all ages are more likely
to have incorrect inhalation technique through a
pMDI than males.43
Older patients with asthma often have
poor inhalation technique,44,45 cognitive function
being an important determinant of correct
inhalation technique,44 the ability to learn correct
inhalation technique46 and the ability to
retain it.47 In addition, some individuals with a
normal abbreviated mental test score who are
neurologically intact on examination are never-
theless unable to perform an inhalation corr-
ectly through a pMDI despite adequate training
and reinforcement48 possibly due to unde-
tected cognitive impairment and subclinical
dyspraxia.49 Indeed, patients with a minimental
test score of o23/30 or an ideomotor dyspraxia
score o14/20 are unlikely to use a pMDI
correctly.49
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G.K. Crompton et al.1490What about a relationship between age and
correct DPI use? DeBoeck et al.50 showed that
although the vast majority of children older
than 8 years could perform every step of the
inhalation manoeuvre through the Turbuhalers
correctly after training, only half of the children
younger than 8 years were able to do so. Inability
to generate a sufficiently high inspiratory flow
rate through the device was cited as the reason
for failure. Other investigators have shown an
age dependency of peak inspiratory flow (PIF)
rate generated through the Turbuhalers51 and
through the Clickhalers.52 Children aged 5 years
and older, or with a weight over 20 kg or a height
over 113 cm were able to generate inspiratory flow
rates for effective drug delivery through the
Turbuhalers.53
The patient’s lung function also determines
whether she/he derives complete benefit from
the inhaler device. Aerosolisation and drug delivery
from DPIs depend to a large extent on a sufficiently
high PIF rate generated by the patient. The
patient’s airflow profile is also important in
determining the characteristics of the aerosol
delivered through a DPI.54 Failure to inhale deeply
and forcibly at the start of the inhalation man-
oeuvre means that the drug particles generated are
too big to enter the lungs and are simply deposited
in the mouth and oropharynx where they have no
clinical efficacy.54 Studies with high airflow resis-
tance DPIs such as the Turbuhalers have shown that
in patients with severe obstructive lung disease or
in children with asthma, optimal inspiratory flow
rates are not achieved in all patients.55 Failure to
achieve adequate inspiratory flow rate reduces the
fine particle dose of the drug produced and hence
affects drug deposition and thus efficacy.56 Young
children (i.e. o7 years) also have a higher degree
of variability in PIF rates.57
The low-to-medium airflow resistance of the
Novolizers means that it is suited for use even in
patients with reduced inspiratory flow rates.
Clinical studies have shown that children, elderly
patients, adults with moderate-to-severe asthma
and patients with COPD (stage IIa–III) are all able to
generate sufficient inspiratory flow rates to operate
the Novolizers effectively.58,59 Other DPIs with low
airflow resistance have produced similar re-
sults.60,61
A question often posed is whether inhalers should
be matched to the patient, thereby implying a need
to define in at least some semi-quantitative way
the ‘value’ of particular device characteristics.
Issues which might prove useful for inhaler/patient
matching include ease of correct use; ease of
teaching correct use; accurate and consistent dosedelivery; feedback that the dose has been released
and inhaled correctly, factors which may limit
successful delivery of the dose; a mechanism which
creates awareness of the amount of drug remaining
in the inhaler; the amount and reliability of
instruction provided with the inhaler; the need
for accessory devices such as spacers; the inherent
reliability of the device; the ability to deliver a
range of drugs through the same device model; the
possibility to refill the device; convenience to carry
the device and an appealing design. Clearly,
healthcare providers should recognise that patients
differ and a device should be matched individually
that is most appropriate for their needs and
circumstances.
The importance of these issues will vary accord-
ing to the patient’s and the doctor’s priorities.
Accurate and consistent dose delivery and
ease and convenience of correct use are most
likely to be important to both the patient
and the physician. A device that is easy to teach
to use correctly might be more appealing to busy
GPs with limited time in their daily schedules
and might be better suited for children and
elderly patients (who may find learning new skills
difficult). An intelligent dose counter that counts
the inhalations taken and helps the physicians to
monitor patient’s compliance is important for
those patients who might forget whether they have
taken their medication or simply to check how
much medication is left. A multiple feedback
mechanism for correctly performed inhalation
would be useful for those patients who like
to be assured that they have taken their medi-
cation correctly. The ability to deliver a range of
drugs is an important issue for those patients who
take more than one drug to control their asthma
(e.g. a short acting b2-agonist and an ICS).
A refillable device and no propellant gases
would be important to the environmentally aware
patient. Finally, the possibility to conveniently
carry the device and a visually appealing design
may be important to younger patients.
However, the concept of matching an inhaler
to a patient becomes redundant if inhaler avail-
ability is a problem. One question posed by
ADMIT is whether the choice of device should be
regulated locally at the point of presc-
ription, nationally or internationally. Other factors
that influence inhaler choice include the cost
of the device, whether pharmacists are free to
distribute generically, whether the same type of
device can be used to deliver a range of drugs
and whether more than one drug could be
administered through a single device (i.e. combi-
nation products).
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least one inhaler correctly. However, it is
clear from the available data that patients do
forget instructions on correct inhalation tech-
nique and skills for correct inhalation technique
deteriorate over time and therefore active re-
education is critical to maintain correct inhalation
technique. Ideally, GPs and nurses should teach
patients how to use their inhalers correctly when
they are prescribed, referring to their local
pulmonologist(s) for inhaler specific details of
inhalation technique to ensure appropriate
choice and correct use. However, the typical busy
GP or nurse in a practice often has insufficient time
or inadequate materials to do this. As an alter-
native, the local pharmacist could play an impor-
tant role in reinforcing correct inhalation
technique, both when the drug is prescribed for
the first time and also when the prescription is
repeated. Increasing awareness of the importance
of correct inhalation technique for effective
asthma management is a crucial first step towards
improving asthma control.
Effective inhalation therapy using pMDIs and DPIs
is the cornerstone of asthma management, but
what is the best way of teaching correct inhalation
technique? Methods used at present include verbal
instruction, provision of written material such as
patient information leaflets, face-to-face demon-
stration; and multi-media methods such as video
demonstrations, touch-screen computer or web-
based teaching.
Not everyone is able or willing to read written
information. Studies show that individual training
in inhalation technique results in greater improve-
ment in inhaler knowledge among hospital pharma-
cists than provision of written materials.62
However, it is worth noting that the advantage of
individual training may be short lived.62 The use of
video instruction has been found to be as effective
as personal instruction and significantly superior to
the use of patient information leaflets in teaching
correct inhalation technique.63,64
Multi-media methods are an alternative for
teaching and reinforcing correct inhalation techni-
que.65 A recent study showed that use of a multi-
media and touch-screen computer improved the
patient’s inhalation technique more effectively
than provision of a patient information leaflet,
particularly concerning coordination of actuation
and inhalation through a pMDI.65 This form of
education was acceptable to patients of all age
groups and could be more widely used in primary
care. Adolescents in particular tend to respond
better to multi-media teaching of inhalation
technique in the form of interactive video ratherthan to education provided via written instructions
on the patient information leaflet of the inhaler.66
Elderly patients often receive little or no teach-
ing on the correct use of their inhalers. A study that
evaluated a patient teaching programme designed
specifically for elderly people showed that one-to-
one teaching sessions resulted in significant im-
provement in inhalation technique, but whether
this improvement was sustained over time was not
determined.67
ADMIT recommends that instructions for correct
inhalation technique for each inhaler device cur-
rently on the market should be compiled by an
Official Board with instructions made readily
accessible on the web. Local asthma associations
and patient groups could also be involved in
promoting the importance and teaching and re-
inforcing of correct inhalation technique. Informa-
tion could be disseminated by the use of dedicated
literature, school visits by healthcare professionals
as well as through patient advocacy groups. Other
evidence-based recommendations are summarised
in Table 2.
ADMIT provides additional recommendations for
asthma therapy adjustment. At each consultation a
patient attends the physician should check that the
patient has few symptoms, is leading a normal life,
performs regularly exercises, is on low-dose relief
medication and is not taking any additional
medication. If all these conditions are met then
therapy should be stepped down according to
treatment guidelines and another appointment
scheduled for a symptom check. If, however, the
patient answers ‘no’ to any of these checklist
questions then compliance and aggravating factors
should be assessed. Most importantly, inhalation
technique should be assessed. If inhalation techni-
que is incorrect, a change in inhaler device should
be considered. If, on the other hand, inhalation
technique is correct then asthma therapy should be
stepped up according to the treatment guidelines
and another appointment scheduled in order to
check symptoms (Fig. 1).
Problems encountered by patients using inhaler
devices correctly have led to the concept of one
universal ‘ideal’ inhaler. However, bearing in
mind inherent variability among patients, it may
be preferable that inhalers should be matched to
the patient, specifically with respect to ease of
correct use, size, possibility to guide the patient
through the inhalation, feedback of the dose
delivered and of correctly performed inhalation,
availability of an intelligent dose counter with
indication of the number of correctly performed
inhalations, need for accessory devices, inhaler
reliability and cost.
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Table 2 Recommendations of the Aerosol Drug Management Improvement Team (ADMIT).
 Inhalers should be matched to the patient as different inhaler characteristics will be important to different
patients.
 In young children, if pMDIs are prescribed, they should be used with a spacer device.
 An alternative to a pMDI should be considered in elderly patients with a minimental test score o23/30 or an
ideomotor dyspraxia score o14/20 as they are unlikely to have correct inhalation technique through a pMDI.
 The patient’s potential PIF should be estimated before DPI prescription. Those patients with severe airflow
obstruction, children and the elderly would benefit from an inhaler device with a low airflow resistance.
 Before prescribing a DPI, check that the patient can inhale deeply and forcibly at the start of the inhalation
manoeuvre as airflow profile affects particle size produced and hence drug deposition and efficacy.
 Where possible, one patient should have one inhaler.
 Establish an Official Board to compile instructions for correct inhalation technique for each inhaler device
currently on the market.
 Instructions for correct inhaler use should be made readily accessible on a dedicated web site.
 Training in correct inhalation technique is essential for patients and healthcare professionals.
 Inhalation technique should be checked and reinforced at regular intervals (e.g. every time a patient is
prescribed a new inhaler).
 Teaching correct inhalation techniques should be tailored to the patient’s needs and preferences: written
material alone is insufficient to teach correct inhalation technique (one-to-one, group and video tuition are
superior tools); group instruction in correct inhalation technique appears to be more effective than personal
one-to-one instruction and equally effective like video instruction; younger patients may benefit more from
multi-media teaching methods; elderly patients respond well to one-to-one tuition.
DPI, dry powder inhaler; PIF, peak inspiratory flow; pMDI, pressurised metered dose inhaler.
Figure 1 Asthma therapy adjustment flow chart.
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